Associations of Diabetes Mellitus With/Without Diabetic Retinopathy and Cognitive Outcomes in Older Adults: The Potential Role of the Dietary Inflammatory Index in a Multi-Dataset Observational Study

Why It Matters

The findings highlight diet‑driven inflammation as a modifiable pathway linking diabetes severity to brain health, offering a potential target for preventing dementia in the rapidly growing elderly diabetic population.

Key Takeaways

• Diabetes increases risk of cognitive impairment; diabetic retinopathy further elevates risk
• Higher Dietary Inflammatory Index scores link to poorer cognition in older adults
• Mediation analysis shows DII explains 4–15% of diabetes‑related cognitive decline
• Findings consistent across US NHANES, UK Biobank, and Chinese Wenzhou cohorts

Pulse Analysis

The aging of the global population is amplifying the public‑health burden of diabetes, with more than 20% of Americans over 60 now diagnosed. Beyond classic complications such as cardiovascular disease, mounting evidence ties diabetes to accelerated cognitive decline and dementia. Diabetic retinopathy, a microvascular eye disease affecting roughly one‑third of diabetics, serves as a clinical barometer of disease severity and, as this study shows, signals an even greater risk of neurocognitive deficits. Understanding these links is crucial for clinicians who must anticipate and monitor cognitive health in older patients with diabetes.

Dietary patterns play a pivotal role in both glycemic control and systemic inflammation. The Dietary Inflammatory Index quantifies how pro‑ or anti‑inflammatory a person’s diet is, based on nutrient intake. In the three diverse cohorts examined, higher DII scores consistently correlated with lower scores on memory, fluency and processing speed tests, as well as increased dementia incidence. Mediation models revealed that inflammation‑driven diet explains a modest but meaningful portion—between 4% and 15%—of the diabetes‑cognition relationship, suggesting that dietary modification could blunt the neurodegenerative trajectory in this high‑risk group.

For policymakers and health systems, these insights point to actionable interventions. Integrating anti‑inflammatory dietary counseling into diabetes management programs could address a dual threat: improving metabolic outcomes while preserving cognitive function. However, the observational nature of the data warrants caution; randomized controlled trials are needed to confirm causality and to define optimal dietary prescriptions. Until then, clinicians should consider assessing patients’ DII‑related habits as part of a comprehensive strategy to mitigate the looming dementia epidemic among older adults with diabetes.